デジタルバイオマーカーの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2131)
◆英語タイトル:Global Digital Biomarker Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2131
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、デジタルバイオマーカーの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(安全性バイオマーカー、検証性バイオマーカー、有効性バイオマーカー)、用途別市場規模(睡眠&運動、心臓血管、気分&行動、痛み管理、呼吸器状態)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・デジタルバイオマーカーの市場動向
・企業の競争状況、市場シェア
・デジタルバイオマーカーの種類別市場規模(安全性バイオマーカー、検証性バイオマーカー、有効性バイオマーカー)
・デジタルバイオマーカーの用途別市場規模(睡眠&運動、心臓血管、気分&行動、痛み管理、呼吸器状態)
・デジタルバイオマーカーの北米市場規模2016-2027(アメリカ、カナダ)
・デジタルバイオマーカーの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・デジタルバイオマーカーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・デジタルバイオマーカーの中南米市場規模2016-2027(メキシコ、ブラジル)
・デジタルバイオマーカーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(ActiGraph、Akili Interactive Labs、AliveCor、Fitbit、HumanAPI、Novartis、Pfizer、Roche、Sanofi、Takeda Pharmaceuticals)
・結論
【レポートの概要】

Digital biomarker refers to the use of modern computer technology for data collection and analysis to apply to changes in personal elements such as sleep, breathing, etc.

Market Analysis and Insights: Global Digital Biomarker Market
The global Digital Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Biomarker market.

Global Digital Biomarker Scope and Market Size
Digital Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Safety Biomarker
Validation Biomarker
Efficacy Biomarker

Segment by Application
Sleep and Movement
Cardiovascular
Mood and Behavior
Pain Management
Respiratory Conditions

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ActiGraph
Akili Interactive Labs
AliveCor
Fitbit
HumanAPI
Novartis
Pfizer
Roche
Sanofi
Takeda Pharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety Biomarker
1.2.3 Validation Biomarker
1.2.4 Efficacy Biomarker
1.3 Market by Application
1.3.1 Global Digital Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sleep and Movement
1.3.3 Cardiovascular
1.3.4 Mood and Behavior
1.3.5 Pain Management
1.3.6 Respiratory Conditions
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Digital Biomarker Market Perspective (2016-2027)
2.2 Digital Biomarker Growth Trends by Regions
2.2.1 Digital Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Digital Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Digital Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Digital Biomarker Industry Dynamic
2.3.1 Digital Biomarker Market Trends
2.3.2 Digital Biomarker Market Drivers
2.3.3 Digital Biomarker Market Challenges
2.3.4 Digital Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Digital Biomarker Players by Revenue
3.1.1 Global Top Digital Biomarker Players by Revenue (2016-2021)
3.1.2 Global Digital Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Digital Biomarker Revenue
3.4 Global Digital Biomarker Market Concentration Ratio
3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2020
3.5 Digital Biomarker Key Players Head office and Area Served
3.6 Key Players Digital Biomarker Product Solution and Service
3.7 Date of Enter into Digital Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Digital Biomarker Breakdown Data by Type
4.1 Global Digital Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Digital Biomarker Forecasted Market Size by Type (2022-2027)

5 Digital Biomarker Breakdown Data by Application
5.1 Global Digital Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Digital Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Digital Biomarker Market Size (2016-2027)
6.2 North America Digital Biomarker Market Size by Type
6.2.1 North America Digital Biomarker Market Size by Type (2016-2021)
6.2.2 North America Digital Biomarker Market Size by Type (2022-2027)
6.2.3 North America Digital Biomarker Market Size by Type (2016-2027)
6.3 North America Digital Biomarker Market Size by Application
6.3.1 North America Digital Biomarker Market Size by Application (2016-2021)
6.3.2 North America Digital Biomarker Market Size by Application (2022-2027)
6.3.3 North America Digital Biomarker Market Size by Application (2016-2027)
6.4 North America Digital Biomarker Market Size by Country
6.4.1 North America Digital Biomarker Market Size by Country (2016-2021)
6.4.2 North America Digital Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Digital Biomarker Market Size (2016-2027)
7.2 Europe Digital Biomarker Market Size by Type
7.2.1 Europe Digital Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Digital Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Digital Biomarker Market Size by Type (2016-2027)
7.3 Europe Digital Biomarker Market Size by Application
7.3.1 Europe Digital Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Digital Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Digital Biomarker Market Size by Application (2016-2027)
7.4 Europe Digital Biomarker Market Size by Country
7.4.1 Europe Digital Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Digital Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Digital Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Digital Biomarker Market Size by Type
8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Digital Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Digital Biomarker Market Size by Application
8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Digital Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Digital Biomarker Market Size by Region
8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Digital Biomarker Market Size (2016-2027)
9.2 Latin America Digital Biomarker Market Size by Type
9.2.1 Latin America Digital Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Digital Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Digital Biomarker Market Size by Type (2016-2027)
9.3 Latin America Digital Biomarker Market Size by Application
9.3.1 Latin America Digital Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Digital Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Digital Biomarker Market Size by Application (2016-2027)
9.4 Latin America Digital Biomarker Market Size by Country
9.4.1 Latin America Digital Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Digital Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Digital Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Digital Biomarker Market Size by Type
10.2.1 Middle East & Africa Digital Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Digital Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Digital Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Digital Biomarker Market Size by Application
10.3.1 Middle East & Africa Digital Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Digital Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Digital Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Digital Biomarker Market Size by Country
10.4.1 Middle East & Africa Digital Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Digital Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ActiGraph
11.1.1 ActiGraph Company Details
11.1.2 ActiGraph Business Overview
11.1.3 ActiGraph Digital Biomarker Introduction
11.1.4 ActiGraph Revenue in Digital Biomarker Business (2016-2021)
11.1.5 ActiGraph Recent Development
11.2 Akili Interactive Labs
11.2.1 Akili Interactive Labs Company Details
11.2.2 Akili Interactive Labs Business Overview
11.2.3 Akili Interactive Labs Digital Biomarker Introduction
11.2.4 Akili Interactive Labs Revenue in Digital Biomarker Business (2016-2021)
11.2.5 Akili Interactive Labs Recent Development
11.3 AliveCor
11.3.1 AliveCor Company Details
11.3.2 AliveCor Business Overview
11.3.3 AliveCor Digital Biomarker Introduction
11.3.4 AliveCor Revenue in Digital Biomarker Business (2016-2021)
11.3.5 AliveCor Recent Development
11.4 Fitbit
11.4.1 Fitbit Company Details
11.4.2 Fitbit Business Overview
11.4.3 Fitbit Digital Biomarker Introduction
11.4.4 Fitbit Revenue in Digital Biomarker Business (2016-2021)
11.4.5 Fitbit Recent Development
11.5 HumanAPI
11.5.1 HumanAPI Company Details
11.5.2 HumanAPI Business Overview
11.5.3 HumanAPI Digital Biomarker Introduction
11.5.4 HumanAPI Revenue in Digital Biomarker Business (2016-2021)
11.5.5 HumanAPI Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Digital Biomarker Introduction
11.6.4 Novartis Revenue in Digital Biomarker Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Digital Biomarker Introduction
11.7.4 Pfizer Revenue in Digital Biomarker Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Digital Biomarker Introduction
11.8.4 Roche Revenue in Digital Biomarker Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Digital Biomarker Introduction
11.9.4 Sanofi Revenue in Digital Biomarker Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Takeda Pharmaceuticals
11.10.1 Takeda Pharmaceuticals Company Details
11.10.2 Takeda Pharmaceuticals Business Overview
11.10.3 Takeda Pharmaceuticals Digital Biomarker Introduction
11.10.4 Takeda Pharmaceuticals Revenue in Digital Biomarker Business (2016-2021)
11.10.5 Takeda Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ デジタルバイオマーカーの世界市場規模・現状・予測2021年-2027年(Global Digital Biomarker Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。